REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Anjakan Paradigma Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing | Pharmacies and Drug Stores
Full name: Anjakan Paradigma Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Stores specialized in retail sale of pharmaceuticals, medical and orthopaedic goods;export and import of medicinal active substances to be used for their pharmacological properties in the manufacture of medicaments;export and import of other pharmaceuticals,medicinal chemical and botanical products

Headquarters
F04-17, Komersil Southkey Mozek, Persiaran Southkey 1, Kota Southkey
Johor Bahru; Johor; Postal Code: 80150

Contact Details: Purchase the Anjakan Paradigma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Anjakan Paradigma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Anjakan Paradigma Sdn. Bhd. report to view the information.
Incorporation Date:
February 25, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Anjakan Paradigma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
134.45%▲
Total operating revenue
134.45%▲
Operating profit (EBIT)
15.2%▲
Net Profit (Loss) for the Period
15.17%▲
Total assets
72.77%▲
Total equity
78.91%▲
Operating Profit Margin (ROS)
-4.31%▼
Net Profit Margin
-3.58%▼
Return on Equity (ROE)
-22.22%▼
Quick Ratio
0.21%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo